Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 509204, 9 pages
http://dx.doi.org/10.1155/2014/509204
Review Article

Laboratory Markers of Ventricular Arrhythmia Risk in Renal Failure

Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, T. Vladimirescu Street 14, 300173 Timisoara, Romania

Received 28 February 2014; Revised 21 April 2014; Accepted 22 April 2014; Published 26 May 2014

Academic Editor: Patrizia Cardelli

Copyright © 2014 Ioana Mozos. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Ronco, P. McCullough, S. D. Anker et al., “Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative,” European Heart Journal, vol. 31, no. 6, pp. 703–711, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Polak-Jonkisz, K. Laszki-Szczachor, L. Purzyc et al., “Usefulness of body surface potential mapping for early identification of the intraventricular conduction disorders in young patients with chronic kidney disease,” Journal of Electrocardiology, vol. 42, no. 2, pp. 165–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. S. Hager, S. Jain, J. Blackwell, B. Culp, J. Song, and C. D. Chiles, “Effect of renal function on survival after implantable cardioverter defibrillator placement,” American Journal of Cardiology, vol. 106, no. 9, pp. 1297–1300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Pilmore, G. Dogra, M. Roberts et al., “Cardiovascular disease in patients with chronic kidney disease,” Nephrology, vol. 19, no. 1, pp. 3–10, 2014. View at Publisher · View at Google Scholar
  5. M. P. Tokmakova, H. Skali, S. Kenchaiah et al., “Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival and Ventricular Enlargement (SAVE) study,” Circulation, vol. 110, no. 24, pp. 3667–3673, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Clark, H. Krum, and I. Hopper, “Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction,” European Journal of Heart Failure, vol. 16, no. 1, pp. 41–48, 2014. View at Publisher · View at Google Scholar
  7. F. D. De Castro, P. Castro Chaves, and A. F. Lette-Moreira, “Sindrome cardiorrenal e suas implicacoes fisiopatologicas,” Revista Portuguesa de Cardiologia, vol. 29, no. 10, pp. 1535–1554, 2010. View at Google Scholar
  8. I. R. Whitman, H. I. Feldman, and R. Deo, “CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches,” Journal of the American Society of Nephrology, vol. 23, pp. 1029–1039, 2012. View at Google Scholar
  9. P. Gupta, C. Patel, H. Patel et al., “Tp-e/QT ratio as an index of arrhythmogenesis,” Journal of Electrocardiology, vol. 41, no. 6, pp. 567–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Al-Khatib, N. M. Allen LaPointe, J. M. Kramer, and R. M. Califf, “What clinicians should know about the QT interval,” Journal of the American Medical Association, vol. 289, no. 16, pp. 2120–2127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. P. M. Rautaharju, B. Surawicz, and L. S. Gettes, “AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval A scientific statement from the american heart association electrocardiography and arrhythmias committee, council on clinical cardiology; the american college of cardiology foundation; and the heart rhythm society endorsed by the international society for computerized,” Journal of the American College of Cardiology, vol. 53, no. 11, pp. 982–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. P. Day, J. M. McComb, and R. W. F. Campbell, “QT dispersion: an indication of arrhythmia risk in patients with long QT intervals,” British Heart Journal, vol. 63, no. 6, pp. 342–344, 1990. View at Google Scholar · View at Scopus
  13. B. Surawicz, “Will QT dispersion play a role in clinical decision-making?” Journal of Cardiovascular Electrophysiology, vol. 7, no. 8, pp. 777–784, 1996. View at Google Scholar · View at Scopus
  14. M. Malik and V. Batchvarov, QT Dispersion, Futura Publishing, New York, NY, USA, 2000.
  15. I. Mozos, C. Serban, and R. Mihaescu, “Late ventricular potentials in cardiac and extracardiac diseases,” in Cardiac Arrythmias-New Considerations, F. R. Breijo-Marquez, Ed., In Tech, 2012. View at Google Scholar
  16. P. R. B. Barbosa, M. O. D. Sousa, E. C. Barbosa, A. D. S. Bomfim, P. Ginefra, and J. Nadal, “Analysis of the prevalence of ventricular late potentials in the late phase of myocardial infarction based on the site of infarction,” Arquivos Brasileiros de Cardiologia, vol. 78, no. 4, pp. 352–363, 2002. View at Google Scholar · View at Scopus
  17. J. J. Goldberger, M. E. Cain, S. H. Hohnloser et al., “American heart association/American college of cardiology foundation/heart rhythm society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. A scientific statement from the American heart association council on clinical cardiology committee on electrocardiography and arrhythmias and council on epidemiology and prevention,” Heart Rhythm, vol. 5, no. 10, pp. e1–e21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Chandra, R. L. Sands, B. W. Gillespie et al., “Predictors of heart rate variability and its prognostic significance in chronic kidney disease,” Nephrology Dialysis Transplantation, vol. 27, no. 2, pp. 700–709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Sipahioglu, I. Kocyigit, A. Unal et al., “Effect of serum electrolyte and bicarbonate concentration changes during hemodialysis sessions on heart rate variability,” Journal of Nephrology, vol. 25, no. 6, pp. 1067–1074, 2012. View at Publisher · View at Google Scholar
  20. P. Kes, D. Milicic, and N. Basic-Jukic, “How to motivate nephrologists to think more “cardiac” and cardiologists to think more “renal”?” Acta Medica Croatica, vol. 65, no. 3, pp. 85–89, 2011. View at Google Scholar
  21. I. Goldenberg, A. J. Moss, S. McNitt et al., “Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction,” American Journal of Cardiology, vol. 98, no. 4, pp. 485–490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. Saxon, M. R. Bristow, J. Boehmer et al., “Predictors of sudden cardiac death and appropriate shock in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial,” Circulation, vol. 114, no. 25, pp. 2766–2772, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Deo, C. L. Wassel Fyr, L. F. Fried et al., “Kidney dysfunction and fatal cardiovascular disease-an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study,” American Heart Journal, vol. 155, no. 1, pp. 62–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Mozos, M. Hancu, and L. Susan, “Signal averaged electrocardiography and renal function in hypertensive patients,” in Latest Advances in Biology, Environment and Ecology, R. Raducanu, N. Mastorakis, R. Neck, V. Niola, and K. L. Ng, Eds., WSEAS Press, 2012. View at Google Scholar
  25. D. Dalal, J. S. S. G. De Jong, F. V. Y. Tjong et al., “Mild-to-moderate kidney dysfunction and the risk of sudden cardiac death in the setting of acute myocardial infarction,” Heart Rhythm, vol. 9, no. 4, pp. 540–545, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. V. M. Van Deursen, K. Damman, A. A. Voors et al., “Prognostic value of plasma NGAL for mortality in heart failure patients,” Circulation: Heart Failure, vol. 7, no. 1, pp. 35–42, 2014. View at Google Scholar
  27. S. Lindberg, S. H. Pedersen, R. Mogelvang et al., “Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention,” Journal of the American College of Cardiology, vol. 60, pp. 339–345, 2012. View at Publisher · View at Google Scholar
  28. S. Di Somma, L. Magrini, B. De Berardinis et al., “Additive value of blood neutrophil gelatinase associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department,” Critical Care, vol. 17, article R29, 2013. View at Google Scholar
  29. R. A. De Boer, A. A. Voors, P. Muntendam, W. H. Van Gilst, and D. J. Van Veldhuisen, “Galectin-3: a novel mediator of heart failure development and progression,” European Journal of Heart Failure, vol. 11, no. 9, pp. 811–817, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. D. M. Okamura, K. Pasichnyk, J. M. Lopez-Guisa et al., “Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis,” American Journal of Physiology: Renal Physiology, vol. 300, no. 1, pp. F245–F253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. H. B. Wu, “Biomarkers beyond the natriuretic peptides for chronic heart failure: galectin-3 and soluble ST2,” The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine, vol. 23, no. 3, 2012. View at Google Scholar
  32. D. A. Pascual-Figal, J. Ordoñez-Llanos, P. L. Tornel et al., “Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction,” Journal of the American College of Cardiology, vol. 54, no. 23, pp. 2174–2179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. Scott, P. A. Townsend, L. L. Ng et al., “Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers,” Europace, vol. 13, no. 10, pp. 1419–1427, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Hoffmeister, N. A. M. Estes, and A. C. Garlitski, “Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator,” Journal of Interventional Cardiac Electrophysiology, vol. 35, no. 2, pp. 227–234, 2012. View at Google Scholar
  35. S. Patanè, F. Marte, G. Di Bella, A. Currò, and S. Coglitore, “QT interval prolongation, torsade de pointes and renal disease,” International Journal of Cardiology, vol. 130, no. 2, pp. e71–e73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Karayaylali, M. San, G. Kudaiberdieva et al., “Heart rate variability, left ventricular functions, and cardiac autonomic neuropathy in patients undergoing chronic hemodialysis,” Renal Failure, vol. 25, no. 5, pp. 845–853, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. J. H. Ix, M. G. Shlipak, G. M. Chertow, S. Ali, N. B. Schiller, and M. A. Whooley, “Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the heart and soul study,” Journal of Cardiac Failure, vol. 12, no. 8, pp. 601–607, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. P. S. Cuculich, J. M. Sánchez, R. Kerzner et al., “Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death,” Pacing and Clinical Electrophysiology, vol. 30, no. 2, pp. 207–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Mihaescu, C. Serban, S. Dragan et al., “Diabetes and renal disease,” in Diseases of Renal Parenchyma, M. Sahay, Ed., In Tech, 2012. View at Google Scholar
  40. R. Deo, N. Sotoodehnia, R. Katz et al., “Cystatin C and sudden cardiac death risk in the elderly,” Circulation: Cardiovascular Quality and Outcomes, vol. 3, no. 2, pp. 159–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. G. Shlipak, L. F. Fried, M. Cushman et al., “Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors,” Journal of the American Medical Association, vol. 293, no. 14, pp. 1737–1745, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. N. El-Sherif and G. Turitto, “Electrolyte disorders and arrhythmogenesis,” Cardiology Journal, vol. 18, no. 3, pp. 233–245, 2011. View at Google Scholar · View at Scopus
  43. C. Fisch, “Relation of electrolyte disturbances to cardiac arrhythmias,” Circulation, vol. 47, no. 2, pp. 408–419, 1973. View at Google Scholar · View at Scopus
  44. D. Green, H. D. Green, D. I. New, and P. A. Kalra, “The clinical significance of hyperkalaemia-associated repolarization abnormalities in end-stage renal disease,” Nephrology Dialysis Transplantation, vol. 28, pp. 99–105, 2013. View at Publisher · View at Google Scholar
  45. L. M. Einhorn, M. Zhan, V. D. Hsu et al., “The frequency of hyperkalemia and its significance in chronic kidney disease,” Archives of Internal Medicine, vol. 169, no. 12, pp. 1156–1162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Greenspan, C. Wunsch, and C. Fisch, “T wave of normo- and hyperkalemic canine heart: effect of vagal stimulation,” The American Journal of Physiology, vol. 208, pp. 954–958, 1965. View at Google Scholar · View at Scopus
  47. W. A. Parham, A. A. Mehdirad, K. M. Biermann, and C. S. Fredman, “Hyperkalemia revisited,” Texas Heart Institute Journal, vol. 33, no. 1, pp. 40–47, 2006. View at Google Scholar · View at Scopus
  48. E. A. Gelzayd and D. Holzman, “Electrocardiographic changes of hyperkalemia simulating acute myocardial infarction. Report of a case,” Diseases of the Chest, vol. 51, no. 2, pp. 211–212, 1967. View at Google Scholar · View at Scopus
  49. D. Kaji and T. Khan, “Na-K pump in chronic renal failure,” American Journal of Physiology, vol. 252, pp. F785–F793, 1987. View at Google Scholar
  50. H. M. Szerlip, J. Weiss, and I. Singer, “Profound hyperkalemia without electrocardiographic manifestations,” American Journal of Kidney Diseases, vol. 7, no. 6, pp. 461–465, 1986. View at Google Scholar · View at Scopus
  51. D. Dreyfuss, G. Jondeau, R. Couturier, J. Rahmani, P. Assayag, and F. Coste, “Tall T waves during metabolic acidosis without hyperkalemia: a prospective study,” Critical Care Medicine, vol. 17, no. 5, pp. 404–408, 1989. View at Google Scholar · View at Scopus
  52. A. Yildiz, V. Akkaya, S. Sahin et al., “QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients,” Peritoneal Dialysis International, vol. 21, no. 2, pp. 186–192, 2001. View at Google Scholar · View at Scopus
  53. S. Aslam, E. A. Friedman, and O. Ifudu, “Electrocardiography is unreliable in detecting potentially lethal hyperkalaemia in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 17, no. 9, pp. 1639–1642, 2002. View at Google Scholar · View at Scopus
  54. M. Voiculescu, C. Ionescu, and G. Ismail, “Frequency and prognostic significance of QT prolongation in chronic renal failure patients,” Romanian Journal of Internal Medicine, vol. 44, no. 4, pp. 407–417, 2006. View at Google Scholar · View at Scopus
  55. F. Wolf and A. Hilewitz, “Hypomagnesaemia in patients hospitalized in internal medicine is associated with increased mortality,” International Journal of Clinical Practice, vol. 68, no. 1, pp. 111–116, 2014. View at Publisher · View at Google Scholar
  56. D. R. Mouw, R. A. Latessa, and E. J. Sullo, “What are the causes of hypomagnesemia?” Journal of Family Practice, vol. 54, no. 2, pp. 156–178, 2005. View at Google Scholar · View at Scopus
  57. J. M. Topf and P. T. Murray, “Hypomagnesemia and hypermagnesemia,” Reviews in Endocrine and Metabolic Disorders, vol. 4, no. 2, pp. 195–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. P. E. G. Foglia, A. Bettinelli, C. Tosetto et al., “Cardiac work up in primary renal hypokalaemia-hypomagnesaemia (Gitelmam syndrome),” Nephrology Dialysis Transplantation, vol. 19, no. 6, pp. 1398–1402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Blomstrom-Lundqvist, K. Caidahl, S. B. Olsson, and A. Rudin, “Electrocardiographic findings and frequency of arrhythmias in Bartter's syndrome,” British Heart Journal, vol. 61, no. 3, pp. 274–279, 1989. View at Google Scholar · View at Scopus
  60. R. Scognamiglio, A. Semplicini, and L. A. Calo, “Myocardial function in Bartter’s and Gitelman’s syndrome,” Kidney International, vol. 64, pp. 366–367, 2003. View at Google Scholar
  61. M. Wanic-Kossowska, P. Guzik, P. Lehman, and S. Czekalski, “Heart rate variability in patients with chronic renal failure treated by hemodialysis,” Polskie Archiwum Medycyny Wewnetrznej, vol. 114, no. 3, pp. 855–861, 2005. View at Google Scholar · View at Scopus
  62. R. Lampert, J. D. Bremner, S. Su et al., “Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men,” American Heart Journal, vol. 156, no. 4, pp. 759e1–759e7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. S. K. Ganesh, A. G. Stack, N. W. Levin, T. Hulbert-Shearon, and F. K. Port, “Association of elevated serum PO4, Ca × PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients,” Journal of the American Society of Nephrology, vol. 12, no. 10, pp. 2131–2138, 2001. View at Google Scholar · View at Scopus
  64. F. O. Bonato, M. M. Lemos, J. L. Cassiolato, and M. E. Canziani, “Prevalence of ventricular arrhythmia and its associated factors in nondialysed chronic kidney disease patients,” PLoS ONE, vol. 8, no. 6, Article ID e66036, 2013. View at Google Scholar
  65. G. Currie and C. Delles, “Proteinuria and its relation to cardiovascular disease,” International Journal of Nephrology and Renovascular Disease, vol. 7, pp. 13–24, 2013. View at Google Scholar
  66. O. Busari, G. Opadijo, T. Olarewaju, A. Omotoso, and A. Jimoh, “Electrocardiographic correlates of microalbuminuria in adult Nigerians with essential hypertension,” Cardiology Journal, vol. 17, no. 3, pp. 281–287, 2010. View at Google Scholar · View at Scopus
  67. K. Wachtell, M. H. Olsen, B. Dahlöf et al., “Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study,” Journal of Hypertension, vol. 20, no. 3, pp. 405–412, 2002. View at Google Scholar
  68. G. F. H. Diercks, A. J. Van Boven, H. L. Hillege et al., “Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population: the PREVEND (Prevention of REnal and Vascular ENdstage Disease) study,” European Heart Journal, vol. 21, no. 23, pp. 1922–1927, 2000. View at Google Scholar · View at Scopus
  69. L. Mykkänen, D. J. Zaccaro, L. E. Wagenknecht, D. C. Robbins, M. Gabriel, and S. M. Haffner, “Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study,” Diabetes, vol. 47, no. 5, pp. 793–800, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. N. Bavbek, H. Yilmaz, H. K. Erdemli et al., “Correlations between iron stores and QTc dispersion in chronic ambulatory peritoneal dialysis patients,” Renal Failure, vol. 36, no. 2, pp. 187–190, 2014. View at Publisher · View at Google Scholar
  71. B. Franczyk-Skora, A. Gluba, M. Banach et al., “Prevention of sudden cardiac death in patients with chronic kidney disease,” BMC Nephrology, vol. 13, article 162, 2012. View at Publisher · View at Google Scholar
  72. M.-A. Morales, C. Gremigni, P. Dattolo et al., “Signal-averaged ECG abnormalities in haemodialysis patients. Role of dialysis,” Nephrology Dialysis Transplantation, vol. 13, no. 3, pp. 668–673, 1998. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. Hosaka, M. Chinushi, K. Iijima, A. Sanada, H. Furushima, and Y. Aizawa, “Correlation between surface and intracardiac electrocardiogram in a patient with inappropriate defibrillation shocks due to hyperkalemia,” Internal Medicine, vol. 48, no. 13, pp. 1153–1156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. C. A. Herzog, J. M. Mangrum, and R. Passman, “Sudden cardiac death and dialysis patients,” Seminars in Dialysis, vol. 21, no. 4, pp. 300–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. M. K. Shamseddin and P. S. Parfrey, “Sudden cardiac death in chronic kidney disease: epidemiology and prevention,” Nature Reviews Nephrology, vol. 7, no. 3, pp. 145–154, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. O. Vonend, L. C. Rump, and E. Ritz, “Sympathetic overactivity—the cinderella of cardiovascular risk factors in dialysis patients,” Seminars in Dialysis, vol. 21, no. 4, pp. 326–330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Covic, M. Diaconita, P. Gusbeth-Tatomir et al., “Haemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease,” Nephrology Dialysis Transplantation, vol. 17, no. 12, pp. 2170–2177, 2002. View at Google Scholar · View at Scopus
  78. L. H. Bignotto, M. E. Kallas, R. J. T. Djouki et al., “Electrocardiographic findings in chronic hemodialysis patients,” Jornal Brasileiro de Nefrologia, vol. 34, no. 3, pp. 235–242, 2012. View at Publisher · View at Google Scholar
  79. F. Milone, S. Urso, M. Garozzo, A. M. Memeo, G. Volpe, and G. Battaglia, “Risk of arrhythmias in hemodialysis patients vs healthy people,” Giornale Italiano di Nefrologia, vol. 21, pp. S241–S246, 2004. View at Google Scholar · View at Scopus
  80. S. Genovesi, C. Dossi, M. R. Viganò et al., “Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients,” Europace, vol. 10, no. 6, pp. 771–777, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. B. Di Iorio, S. Torraca, C. Piscopo et al., “Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects,” Journal of Nephrology, vol. 25, no. 5, pp. 653–660, 2012. View at Google Scholar
  82. I. Girgis, G. Contreras, S. Chakko et al., “Effect of hemodialysis on the signal-averaged electrocardiogram,” American Journal of Kidney Diseases, vol. 34, no. 6, pp. 1105–1113, 1999. View at Google Scholar · View at Scopus
  83. H. Ichikawa, Y. Nagake, and H. Makino, “Signal averaged electrocardiography (SAECG) in patients on hemodialysis,” Journal of Medicine, vol. 28, no. 3-4, pp. 229–243, 1997. View at Google Scholar · View at Scopus
  84. P. P. Frohnert, E. R. Giuliani, M. Friedberg, W. J. Johnson, and W. N. Tauxe, “Statistical investigation of correlations between serum potassium levels and electrocardiographic findings in patients on intermittent hemodialysis therapy,” Circulation, vol. 41, no. 4, pp. 667–676, 1970. View at Google Scholar · View at Scopus
  85. C. P. Kovesdy, D. L. Regidor, R. Mehrotra et al., “Serum and dialysate potassium concentrations and survival in hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 5, pp. 999–1007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. I. A. Checherita, C. David, V. Diaconu, A. Ciocalteu, and I. Lascar, “Potassium level changes—arrhythmia contributing factor in chronic kidney disease patients,” Romanian Journal of Morphology and Embryology, vol. 52, supplement 3, pp. 1047–1050, 2011. View at Google Scholar
  87. O. E. Osadchii, “Mechanisms of hypokalemia-induced ventricular arrhythmogenicity,” Fundamental and Clinical Pharmacology, vol. 24, no. 5, pp. 547–559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. S. E. Näppi, V. K. Virtanen, H. H. T. Saha, J. T. Mustonen, and A. I. Pasternack, “QT(c) dispersion increases during hemodialysis with low-calcium dialysate,” Kidney International, vol. 57, no. 5, pp. 2117–2122, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. J. W. Lohr, S. Slusher, and D. Diederich, “Safety of regional citrate hemodialysis in acute renal failure,” American Journal of Kidney Diseases, vol. 13, no. 2, pp. 104–107, 1989. View at Google Scholar · View at Scopus
  90. F. Afshinnia, H. Doshi, and P. S. Rao, “The effect of different dialysate magnesium concentrations on QTc dispersion in hemodialysis patients,” Renal Failure, vol. 34, no. 4, pp. 408–412, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Melillo, R. Izzo, N. De Luca, and L. Pecchia, “Heart rate variability and renal organ damage in hypertensive patients,” Conference proceedings: IEEE Engineering in Medicine and Biology Society, vol. 2012, pp. 3825–3828, 2012. View at Google Scholar
  92. M. Kyriakidis, S. Voudiclaris, and D. Kremastinos, “Cardiac arrhythmias in chronic renal failure? Holter monitoring during dialysis and everyday activity at home,” Nephron, vol. 38, no. 1, pp. 26–29, 1984. View at Google Scholar · View at Scopus
  93. O. M. Shapira and Y. Bar-Khayim, “ECG changes and cardiac arrhythmias in chronic renal failure patients on hemodialysis,” Journal of Electrocardiology, vol. 25, no. 4, pp. 273–279, 1992. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Dubrava, J. Fekete, and A. Lehotska, “Relation of ventricular late potentials and intradialytic changes in serum electrolytes, ultrafiltration, left ventricular ejection fraction and left ventricular mass index in haemodialysis patients,” Bratislavske Lekarske Listy, vol. 104, no. 12, pp. 388–392, 2003. View at Google Scholar · View at Scopus
  95. A. P. Marcassi, D. C. Yasbek, J. O. M. Pestana et al., “Ventricular arrhythmia in incident kidney transplant recipients: prevalence and associated factors,” Transplant International, vol. 24, no. 1, pp. 67–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. D. C. Yazbek, A. B. de Carvalho, C. S. Barros et al., “Cardiovascular disease in early kidney transplantation: comparison between living and deceased donor recipients,” Transplantation Proceedings, vol. 44, no. 10, pp. 3001–3006, 2012. View at Publisher · View at Google Scholar
  97. M. Zukowski, J. Biernawska, K. Kotfis et al., “Factors influencing QTc interval prolongation during kidney transplantation,” Annals of Transplantation, vol. 16, no. 2, pp. 43–49, 2011. View at Google Scholar · View at Scopus
  98. A. Monfared and A. J. Ghods, “Improvement of maximum corrected QT and corrected QT dispersion in electrocardiography after kidney transplantation,” Iranian Journal of Kidney Diseases, vol. 2, no. 2, pp. 95–98, 2008. View at Google Scholar · View at Scopus